-

Piper Sandler Companies to Announce Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on February 6, 2026

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2025 financial results prior to the opening of the market on Friday, February 6, 2026. The earnings release will be available at the company’s website at pipersandler.com/earnings.

Chad Abraham, chairman and chief executive officer; Deb Schoneman, president; and Kate Clune, chief financial officer, will host a related conference call at 8 a.m. ET (7 a.m. CT) that same day to review the financial results. There will be a question and answer session following the review.

Investors and analysts may participate in the live conference call by dialing 800 330-6710 (in the U.S.) or +1 312 471-1353 (outside the U.S.) and passcode 3387875. Please dial in at least 15 minutes prior to the call time.

A live audio webcast of the conference call will be available through the company’s website at pipersandler.com/earnings. A replay of the conference call will be available after the event through the same link.

Please direct any questions regarding obtaining access to the conference call to Piper Sandler Investor Relations, via email, at investorrelations@psc.com.

ABOUT PIPER SANDLER

Piper Sandler Companies (NYSE: PIPR) is a leading investment bank driven to help clients Realize the Power of Partnership®. Securities brokerage and investment banking services are offered in the U.S. through Piper Sandler & Co., member SIPC and NYSE; in the U.K. through Piper Sandler Ltd., authorized and regulated by the U.K. Financial Conduct Authority; in the EU through Aviditi Capital Advisors Europe GmbH, authorized and regulated by BaFin as a tied agent of AHP Capital Management GmbH; and in Hong Kong through Piper Sandler Hong Kong Ltd., authorized and regulated by the Securities and Futures Commission. Alternative asset management and fixed income advisory services are offered through separately registered advisory affiliates.

© 2026. Since 1895. Piper Sandler Companies. 350 North 5th Street, Suite 1000, Minneapolis, Minnesota 55401

Contacts

Kate Clune
Tel: 212 466-7799
investorrelations@psc.com

Piper Sandler Companies

NYSE:PIPR

Release Summary
Piper Sandler Companies to Announce Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on February 6, 2026
Release Versions

Contacts

Kate Clune
Tel: 212 466-7799
investorrelations@psc.com

More News From Piper Sandler Companies

Piper Sandler Strengthens Energy & Power Investment Banking with the Addition of Tim Carlson

HOUSTON--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Tim Carlson as a managing director on the energy & power investment banking team. Carlson will focus on upstream. “Tim is another strong example of how we are devoted to the energy sector and will continue to bring in top talent to further help our clients achieve their goals. He has been a trusted advisor to senior executives and boards of directors, known for c...

Piper Sandler Completes Acquisition of MENA Growth Partners

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, today announced that it has completed the acquisition of MENA Growth Partners, a merchant bank based in Abu Dhabi that will serve as its strategic investment banking hub in the GCC region. Nabeel Siddiqui, currently a managing director in the Piper Sandler London office, will relocate to the Abu Dhabi office to lead Piper Sandler’s investment banking in the region in addition to maintaining responsibi...

Piper Sandler Expands Healthcare Investment Banking Team with the Addition of Dan Wolf

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Dan Wolf as a managing director in the healthcare investment banking group. Wolf will be based in the Minneapolis office and be focused on advising healthcare technology companies on mergers and acquisitions, strategic partnerships and capital raising transactions. “Dan is a highly respected med tech executive with an impressive track record of advising healthcar...
Back to Newsroom